Correction: MORF4L2 induces immunosuppressive microenvironment and immunotherapy resistance through GRHL2/MORF4L2/H4K12Ac/CSF1 axis in triple-negative breast cancer.
作者信息
Sui Xin-Yi, Cao Shuo-Wen, Song Xiao-Qing, Liu Xi-Yu, Chen Chao, Yan Qingya, Wang Zhi-Qing, Zhang Wen-Juan, Ma Lin-Xiaoxi, Jin Xi, Ma Ding, Xiao Yi, Wu Song-Yang, Xu Ying, Shao Zhi-Ming, Fan Lei
机构信息
Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Key Laboratory of Breast Cancer in Shanghai, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
出版信息
Biomark Res. 2025 Feb 13;13(1):29. doi: 10.1186/s40364-025-00743-9.
Abstract
摘要
相似文献
1
Correction: MORF4L2 induces immunosuppressive microenvironment and immunotherapy resistance through GRHL2/MORF4L2/H4K12Ac/CSF1 axis in triple-negative breast cancer.更正：在三阴性乳腺癌中，MORF4L2通过GRHL2/MORF4L2/H4K12Ac/CSF1轴诱导免疫抑制微环境和免疫治疗耐药性。
Biomark Res. 2025 Feb 13;13(1):29. doi: 10.1186/s40364-025-00743-9.
2
MORF4L2 induces immunosuppressive microenvironment and immunotherapy resistance through GRHL2/MORF4L2/H4K12Ac/CSF1 axis in triple-negative breast cancer.MORF4L2通过GRHL2/MORF4L2/H4K12Ac/CSF1轴在三阴性乳腺癌中诱导免疫抑制微环境和免疫治疗耐药性。
Biomark Res. 2025 Jan 9;13(1):6. doi: 10.1186/s40364-024-00719-1.
3
Nanocarrier-mediated immunogenic chemotherapy for triple negative breast cancer.纳米载体介导的三阴性乳腺癌免疫原性化疗
J Control Release. 2020 Jul 10;323:431-441. doi: 10.1016/j.jconrel.2020.04.040. Epub 2020 Apr 30.
4
PGAM1 suppression remodels the tumor microenvironment in triple-negative breast cancer and synergizes with anti-PD-1 immunotherapy.PGAM1 抑制重塑三阴性乳腺癌的肿瘤微环境，并与抗 PD-1 免疫治疗协同作用。
J Leukoc Biol. 2024 Sep 2;116(3):579-588. doi: 10.1093/jleuko/qiae065.
5
In vivo multidimensional CRISPR screens identify as an immunotherapy target in triple-negative breast cancer.在体多维 CRISPR 筛选鉴定 为三阴性乳腺癌的免疫治疗靶点。
Sci Adv. 2022 Jul;8(26):eabl8247. doi: 10.1126/sciadv.abl8247. Epub 2022 Jun 29.
6
Molecular mechanisms of immunotherapy resistance in triple-negative breast cancer.三阴性乳腺癌免疫治疗耐药的分子机制。
Front Immunol. 2023 Jun 23;14:1153990. doi: 10.3389/fimmu.2023.1153990. eCollection 2023.
7
The GRHL2/ZEB Feedback Loop-A Key Axis in the Regulation of EMT in Breast Cancer.GRHL2/ZEB反馈回路——乳腺癌上皮-间质转化调控中的关键轴
J Cell Biochem. 2017 Sep;118(9):2559-2570. doi: 10.1002/jcb.25974. Epub 2017 May 3.
8
Tumor Microenvironment Multiple Responsive Nanoparticles for Targeted Delivery of Doxorubicin and CpG Against Triple-Negative Breast Cancer.肿瘤微环境多重响应性纳米颗粒用于靶向递送多柔比星和 CpG 治疗三阴性乳腺癌。
Int J Nanomedicine. 2022 Sep 20;17:4401-4417. doi: 10.2147/IJN.S377702. eCollection 2022.
9
Immunomodulator-Mediated Suppressive Tumor Immune Microenvironment Remodeling Nanoplatform for Enhanced Immuno/Chemo/Photothermal Combination Therapy of Triple Negative Breast Cancer.免疫调节剂介导的抑制性肿瘤免疫微环境重塑纳米平台增强三阴性乳腺癌的免疫/化疗/光热联合治疗。
ACS Appl Mater Interfaces. 2023 Nov 22;15(46):53318-53332. doi: 10.1021/acsami.3c14137. Epub 2023 Nov 9.
10
Co-Delivery Nanomicelles for Potentiating TNBC Immunotherapy by Synergetically Reshaping CAFs-Mediated Tumor Stroma and Reprogramming Immunosuppressive Microenvironment.共递纳米胶束通过协同重塑 CAFs 介导的肿瘤基质和重新编程免疫抑制微环境来增强三阴性乳腺癌免疫治疗。
Int J Nanomedicine. 2023 Jul 31;18:4329-4346. doi: 10.2147/IJN.S418100. eCollection 2023.
Zotero 插件